GDRX
Goodrx
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 1
Sell signal 1
Revenue Beats Expectation
EPS Below Expectations
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About GDRX
Goodrx Holdings, Inc.
A provider of healthcare technology and consumer-focused digital healthcare platform in the US
Healthcare Technology
Invalid Date
09/23/2020
NASDAQ Stock Exchange
738
12-31
Common stock
2701 Olympic Boulevard, Santa Monica, CA 90404
--
Goodrx Holdings, Inc., was founded in Delaware. The company aims to address the challenges consumers face in understanding, accessing and delivering healthcare. The company started with a price comparison tool for prescriptions, offering consumers lower drug prices for free. Today, the company believes that its expanded platform can improve the health and financial well-being of American families through easy access to price transparency and affordability solutions for generic and branded drugs, affordable and convenient medical provider consultation through telemedicine and other medical services and information.
Company Financials
EPS
GDRX has released its 2024 Q4 earnings. EPS was reported at 0.09, versus the expected 0.10, missing expectations. The chart below visualizes how GDRX has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
GDRX has released its 2024 Q4 earnings report, with revenue of 198.58M, reflecting a YoY change of 0.99%, and net profit of 6.74M, showing a YoY change of 126.05%. The Sankey diagram below clearly presents GDRX’s revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
